AnaptysBio Inc (ANAB) Implied Volatility Current

Tracking ANAB implied volatility helps you identify when options premiums on AnaptysBio Inc are historically cheap or expensive, and where the best trades are hiding. AnaptysBio Inc implied volatility reflects the market's expectation of future price movement: when ANAB IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor AnaptysBio Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ANAB, tracking metrics like ANAB IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ANAB signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation.

The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ANAB implied volatility sits today versus where it has been. Our scanner ranks AnaptysBio Inc implied volatility against its historical range, surfaces extremes in ANAB IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether AnaptysBio Inc IV is rich or cheap — measure it, then act on it.